ICD10 code of Panhypopituitarism and ICD9 code

Panhypopituitarism is a condition characterized by the underactivity or decreased functioning of the pituitary gland, which is responsible for producing various hormones that regulate several bodily functions. The International Classification of Diseases, 10th Revision (ICD-10) provides a coding system to classify and identify medical conditions for billing and statistical purposes.

The specific ICD-10 code for Panhypopituitarism is E23.0. This code falls under the "Disorders of the Pituitary Gland" category and further specifies the condition as "Hypopituitarism." It is important to note that ICD-10 codes are alphanumeric and consist of a letter followed by two numbers.

In contrast, the International Classification of Diseases, 9th Revision (ICD-9) was the previous coding system used before the transition to ICD-10. The corresponding ICD-9 code for Panhypopituitarism is 253.8. This code is found within the "Other Disorders of the Pituitary Gland" category.

Panhypopituitarism can be caused by various factors, including tumors, infections, trauma, or autoimmune diseases affecting the pituitary gland. Common symptoms may include fatigue, weight loss, decreased libido, low blood pressure, and changes in menstruation for females.

To diagnose Panhypopituitarism, a comprehensive evaluation is typically conducted, including blood tests to assess hormone levels, imaging studies like MRI or CT scans to examine the pituitary gland, and potentially hormone stimulation tests.

Treatment for Panhypopituitarism usually involves hormone replacement therapy to provide the deficient hormones. This may include medications such as hydrocortisone, levothyroxine, estrogen or testosterone replacement, and growth hormone therapy if necessary. Regular monitoring and adjustments of hormone levels are necessary to ensure optimal management of the condition and prevent complications.

It is important to consult with a healthcare professional for an accurate diagnosis, appropriate treatment, and to discuss specific concerns related to Panhypopituitarism.

by Diseasemaps